Literature DB >> 1981426

Twenty-nail dystrophy treated with topical PUVA.

L Halkier-Sørensen1, M Cramers, K Kragballe.   

Abstract

A case of twenty-nail dystrophy treated with topical PUVA is described. The patient, a 19-year-old woman, had a 4-year history of a nail dystrophy involving all finger- and toe-nails. The finger-nail changes were treated with topical PUVA, dose 0.7-1.4 J/cm2 x 3/week. After 7 months excellent improvement was seen, while the untreated toe-nails were unaffected. A maintenance dose of 0.7 J/cm2 x 3/week was necessary to prevent recurrence. We suggest that topical PUVA is worth trying for the treatment of twenty-nail dystrophy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1981426     DOI: 102340/0001555570510511

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  5 in total

1.  Efficacy and Safety of Calcipotriol/Betamethasone Dipropionate Ointment for the Treatment of Trachyonychia: An Open-Label Study.

Authors:  Jung-Min Park; Hyun-Ho Cho; Won-Jeong Kim; Je-Ho Mun; Margaret Song; Hoon-Soo Kim; Hyun-Chang Ko; Byung-Soo Kim; Moon-Bum Kim
Journal:  Ann Dermatol       Date:  2015-07-29       Impact factor: 1.444

Review 2.  Trachyonychia: Review and Update on Clinical Aspects, Histology, and Therapy.

Authors:  Jessica S Haber; Manasmon Chairatchaneeboon; Adam I Rubin
Journal:  Skin Appendage Disord       Date:  2016-09-21

Review 3.  Trachyonychia and Twenty-Nail Dystrophy: A Comprehensive Review and Discussion of Diagnostic Accuracy.

Authors:  Audrey A Jacobsen; Antonella Tosti
Journal:  Skin Appendage Disord       Date:  2016-04-30

4.  Idiopathic 20-nail dystrophy.

Authors:  Camilla Larsen; Anette Bygum
Journal:  BMJ Case Rep       Date:  2016-01-20

5.  Therapeutic Efficacy of Combination Therapy Using Oral Cyclosporine with a Dietary Supplement (Pantogar®) in Twenty-Nail Dystrophy.

Authors:  Su Jin Oh; Jeong Eun Kim; Joo Yeon Ko; Young Suck Ro
Journal:  Ann Dermatol       Date:  2017-08-25       Impact factor: 1.444

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.